Industries - Diabetes Monitoring Devices Market Analysis by Product (Continuous Monitoring, Self-Monitoring), by Distribution Channel (Hospital, Retail, Online), by End User (Hospitals, Homecare Setting, Diagnostic Centre), and by Region – Forecast to 2026

Ablation Technology Market Analysis

Diabetes Monitoring Devices Market Analysis by Product (Continuous Monitoring, Self-Monitoring), by Distribution Channel (Hospital, Retail, Online), by End User (Hospitals, Homecare Setting, Diagnostic Centre), and by Region – Forecast to 2026
May 2021

SKU: N/A Category:
Clear
  • Description
  • Additional information
  • Enquire about

Description

Diabetes Monitoring Devices Market Analysis by Product (Continuous Monitoring, Self-Monitoring), by Distribution Channel (Hospital, Retail, Online), by End User (Hospitals, Homecare Setting, Diagnostic Centre), and by Region - Forecast to 2026

Published: May 2021 | Historical Data: 2018-2020 | Base Year: 2020
SKU: ICI-HC-1117 | Number of Pages: 153 | Category: Medical Devices

The global diabetes monitoring devices market size was valued at USD 14.16 billion in 2020 and is expected to witness a CAGR of 13.0% during the forecast period. Increasing prevalence of diabetes, coupled with the rising geriatric population are key drivers for the growth of the global diabetes monitoring devices market. Additionally, the growing awareness, novel product launches, and increasing demand for health monitoring are some of the other drivers propelling the market growth. However, expensive devices and intensifying competition among market players are expected to restrain the global market growth.

Diabetes Monitoring Devices Market Analysis

By Product

Based on product, the market is segmented into continuous monitoring devices and self-monitoring devices. In 2020, the self-monitoring devices segment accounted for the maximum revenue share owing to affordability of devices and convenient use, worldwide. Continuous monitoring devices segment is projected to grow at the highest CAGR during the forecast period. This is attributed to rising number of hospitalizations with diabetes for multiple medical treatment.

By Distribution Channel

Based on distribution channel, the market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment accounted for largest revenue share in 2020 and is projected to maintain its dominance over the forecast period. Rising consumer awareness for blood glucose monitoring, especially during the COVID-19 pandemic is a key factor that drives the segment growth. The online pharmacies segment is growing at a lucrative CAGR during the forecast period. This is attributed to the increasing trend for online purchases and digital penetration in medical devices industry.

By End User

Based on end user, the market is categorized into hospitals, clinics, diagnostic centres, and homecare settings. The hospitals segment accounted for the highest revenue share in 2020 and is projected to maintain its dominance over the forecast period. The rising demand for blood glucose monitoring during surgeries, modern infrastructure, and comprehensive service offering at hospitals are key factors that drive the segment growth. The homecare settings market is anticipated to grow at the fastest CAGR during the forecast period owing to increasing healthcare expenditure and rising awareness among patients and caregivers.

Regional Insights

In 2020, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of leading medical device manufacturers, advanced healthcare infrastructure, and huge adoption rate in this region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the rising incidences of diabetes, escalating demand for advanced monitoring, and geographic expansion by device manufacturers in this region.

North America Diabetes Monitoring Devices Market Size (2018-2026), USD Billion

North America Diabetes Monitoring Devices Market

Competitor Insights

Some of the key players in the diabetes monitoring devices market are Eli Lilly and Company (U.S.); Sanofi S.A. (France); DexCom, Inc. (U.S.); B. Braun Holding GmbH & Co. KG (Germany); Platinum Equity, LLC (U.S.); Bayer AG (Germany); F. Hoffmann-La Roche AG (Switzerland); Medtronic plc (U.S.); Novo Nordisk A/S (Denmark); and Abbott Laboratories (U.S.). The leading players operating in the diabetes monitoring devices industry are adopting various strategies including novel product launches, R&D investments, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

For instance, in June 2020, Abbott Laboratories received the U.S. FDA approval for its next-generation FreeStyle Libre 2 integrated continuous glucose monitoring system for children and adults with diabetes aged above 4 years. Similarly, in May 2020, Medtronic plc announced the U.S. FDA approval for Android version of its Guardian Connect continuous glucose monitoring (CGM) system.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2018 to 2026. The diabetes monitoring devices market report is categorized into the following segments and sub segments:

Diabetes Monitoring Devices Market, By Product (Revenue, USD Billion, 2018 – 2026)

  • Continuous Monitoring Devices
    • Transmitter & Receiver
    • Sensors
    • Lancets
  • Self-Monitoring Devices
    • Testing Strips
    • Blood Glucose Meter
    • Lancets

Diabetes Monitoring Devices Market, By Distribution Channel (Revenue, USD Billion, 2018 – 2026)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Diabetes Monitoring Devices Market, By End User (Revenue, USD Billion, 2018 – 2026)

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Homecare Settings

Diabetes Monitoring Devices Market, By Region (Revenue, USD Billion, 2018 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Diabetes Monitoring Devices Market Report:

Key Parameters Details
Data Availability 2018-2026
Historical Years 2018-2020
Base Year Considered 2020
Forecast Period 2020-2026
Company Profiles 10
Companies Considered >60
Value Units Value in USD and CAGR in %
Market Segments Product, Distribution Channel, and End User
Regional Coverage North America (U.S. and Canada), Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), and the Middle East & Africa (South Africa, Saudi Arabia, Rest of MEA)
Key Market Players Eli Lilly and Company (U.S.); Sanofi S.A. (France); DexCom, Inc. (U.S.); B. Braun Holding GmbH & Co. KG (Germany); Platinum Equity, LLC (U.S.); Bayer AG (Germany); F. Hoffmann-La Roche AG (Switzerland); Medtronic plc (U.S.); Novo Nordisk A/S (Denmark); and Abbott Laboratories (U.S.)
Custom Analysis Customization up to 60 analyst hours

Diabetes Monitoring Devices Market, By Product (Revenue, USD Billion, 2018 – 2026)

  • Continuous Monitoring Devices
    • Transmitter & Receiver
    • Sensors
    • Lancets
  • Self-Monitoring Devices
    • Testing Strips
    • Blood Glucose Meter
    • Lancets

Diabetes Monitoring Devices Market, By Distribution Channel (Revenue, USD Billion, 2018 – 2026)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Diabetes Monitoring Devices Market, By End User (Revenue, USD Billion, 2018 – 2026)

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Homecare Settings

Diabetes Monitoring Devices Market, By Region (Revenue, USD Billion, 2018 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA
1. Research Methodology
 1.1. Research Objective
 1.2. Study Scope: Market Segments
 1.3. Study Timeframe, Limitations & Currency
 1.4. Domain-Assisted Cognition (DAC) Framework
  1.4.1. Three-stage Research Methodology
   1.4.1.1. Understand Ecosystem
    1.4.1.1.1. Secondary Research
    1.4.1.1.2. Primary Research
    1.4.1.1.3. Internal Repository
   1.4.1.2. Synthesize Information
    1.4.1.2.1. Data Analysis
    1.4.1.2.2. Data Triangulation
   1.4.1.3. Predict/Project Growth
    1.4.1.3.1. Market Size Estimation
     1.4.1.3.1.1. Bottom-up Approach
     1.4.1.3.1.2. Top-down Approach
    1.4.1.3.2. Data Validation
  1.4.2. Two-stage Quality Check Mechanism
   1.4.2.1. Inspection & Reporting
   1.4.2.2. Quality Audit
2. Market Summary
 2.1. Market Definition & Market Landscape
 2.2. Market Segment Snapshot
 2.3. Geographic Market Snapshot
3. Market Dynamics
 3.1. Market Driver Analysis
  3.1.1. Increasing diabetes prevalence
  3.1.2. Rising geriatric people
  3.1.3. Novel product launches
  3.1.4. Growing demand for health monitoring
 3.2. Market Restraint Analysis
  3.2.1. Expensive devices
  3.2.2. Intensifying competition among market players
 3.3. Market Opportunities
  3.3.1. Market penetration by leading device manufacturers in emerging economies
  3.3.2. Increasing healthcare expenditure owing to rise in disposable income
4. Industry Outlook
 4.1. Key Market Trends
 4.2. Value Chain Analysis
 4.3. Porter’s 5 Forces Analysis
 4.4. Pricing Analysis (2018-2020)
 4.5. Product Benchmarking
5. Covid-19 Impact and Deviation Analysis
 5.1. Covid-19 Prevalence Analysis
 5.2. Key Market Trends
 5.3. Market Size Deviation Analysis (2020-2026)
6. Diabetes Monitoring Devices Market Size and Forecast, By Product (2018-2026), USD Million
 6.1. Continuous Monitoring Devices
  6.1.1. Transmitter & Receiver
  6.1.2. Sensors
  6.1.3. Lancets
 6.2. Self-monitoring Devices
  6.2.1. Testing Strips
  6.2.2. Blood glucose meter
  6.2.3. Lancets
7. Diabetes Monitoring Devices Market Size and Forecast, By Distribution Channel (2018-2026), USD Million
 7.1. Hospital Pharmacies
 7.2. Retail Pharmacies
 7.3. Online Pharmacies
8. Diabetes Monitoring Devices Market Size and Forecast, By End User (2018-2026), USD Million
 8.1. Hospitals
 8.2. Clinics
 8.3. Diagnostic Centers
 8.4. Homecare Settings
9. Diabetes Monitoring Devices Market, Regional Analysis (2018-2026), USD Million
 9.1. North America
  9.1.1. Introduction
   9.1.1.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.1.1.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.1.1.3. Market Size & Forecast, by End User (2018-2026), USD Million
   9.1.1.4. Market Size & Forecast, by Country (2018-2026), USD Million
  9.1.2. U.S.
   9.1.2.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.1.2.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.1.2.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.1.3. Canada
   9.1.3.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.1.3.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.1.3.3. Market Size & Forecast, by End User (2018-2026), USD Million
 9.2. Europe
  9.2.1. Introduction
   9.2.1.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.2.1.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.2.1.3. Market Size & Forecast, by End User (2018-2026), USD Million
   9.2.1.4. Market Size & Forecast, by Country (2018-2026), USD Million
  9.2.2. Germany
   9.2.2.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.2.2.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.2.2.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.2.3. UK
   9.2.3.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.2.3.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.2.3.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.2.4. France
   9.2.4.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.2.4.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.2.4.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.2.5. Spain
   9.2.5.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.2.5.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.2.5.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.2.6. Italy
   9.2.6.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.2.6.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.2.6.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.2.7. Russia
   9.2.7.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.2.7.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.2.7.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.2.8. Rest of Europe
   9.2.8.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.2.8.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.2.8.3. Market Size & Forecast, by End User (2018-2026), USD Million
 9.3. Asia Pacific (APAC)
  9.3.1. Introduction
   9.3.1.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.3.1.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.3.1.3. Market Size & Forecast, by End User (2018-2026), USD Million
   9.3.1.4. Market Size & Forecast, by Country (2018-2026), USD Million
  9.3.2. China
   9.3.2.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.3.2.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.3.2.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.3.3. Japan
   9.3.3.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.3.3.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.3.3.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.3.4. India
   9.3.4.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.3.4.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.3.4.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.3.5. Australia
   9.3.5.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.3.5.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.3.5.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.3.6. South Korea
   9.3.6.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.3.6.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.3.6.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.3.7. Rest of Asia Pacific
   9.3.7.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.3.7.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.3.7.3. Market Size & Forecast, by End User (2018-2026), USD Million
 9.4. Latin America (LATAM)
  9.4.1. Introduction
   9.4.1.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.4.1.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.4.1.3. Market Size & Forecast, by End User (2018-2026), USD Million
   9.4.1.4. Market Size & Forecast, by Country (2018-2026), USD Million
  9.4.2. Brazil
   9.4.2.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.4.2.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.4.2.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.4.3. Mexico
   9.4.3.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.4.3.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.4.3.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.4.4. Argentina
   9.4.4.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.4.4.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.4.4.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.4.5. Rest of LATAM
   9.4.5.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.4.5.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.4.5.3. Market Size & Forecast, by End User (2018-2026), USD Million
 9.5. Middle East & Africa (MEA)
  9.5.1. Introduction
   9.5.1.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.5.1.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.5.1.3. Market Size & Forecast, by End User (2018-2026), USD Million
   9.5.1.4. Market Size & Forecast, by Country (2018-2026), USD Million
  9.5.2. South Africa
   9.5.2.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.5.2.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.5.2.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.5.3. Saudi Arabia
   9.5.3.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.5.3.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.5.3.3. Market Size & Forecast, by End User (2018-2026), USD Million
  9.5.4. Rest of MEA
   9.5.4.1. Market Size & Forecast, by Product (2018-2026), USD Million
   9.5.4.2. Market Size & Forecast, by Distribution Channel (2018-2026), USD Million
   9.5.4.3. Market Size & Forecast, by End User (2018-2026), USD Million
10. Competitor Analysis
 10.1. Market Player Comparison
 10.2. Product-wise Player Mapping
 10.3. Region-wise Player Mapping
 10.4. Market Share Analysis
 10.5. Market Position Analysis
 10.6. Recent Development Analysis
11. Company Profiles
 11.1. Eli Lilly and Company (U.S.)
  11.1.1. Company Overview
  11.1.2. Company Financials
  11.1.3. Product Portfolio
  11.1.4. Recent Developments
 11.2. Sanofi S.A. (France)
  11.2.1. Company Overview
  11.2.2. Company Financials
  11.2.3. Product Portfolio
  11.2.4. Recent Developments
 11.3. DexCom, Inc. (U.S.)
  11.3.1. Company Overview
  11.3.2. Company Financials
  11.3.3. Product Portfolio
  11.3.4. Recent Developments
 11.4. B. Braun Holding GmbH & Co. KG (Germany);
  11.4.1. Company Overview
  11.4.2. Company Financials
  11.4.3. Product Portfolio
  11.4.4. Recent Developments
 11.5. Platinum Equity, LLC (U.S.)
  11.5.1. Company Overview
  11.5.2. Company Financials
  11.5.3. Product Portfolio
  11.5.4. Recent Developments
 11.6. Bayer AG (Germany)
  11.6.1. Company Overview
  11.6.2. Company Financials
  11.6.3. Product Portfolio
  11.6.4. Recent Developments
 11.7. F. Hoffmann-La Roche AG (Switzerland)
  11.7.1. Company Overview
  11.7.2. Company Financials
  11.7.3. Product Portfolio
  11.7.4. Recent Developments
 11.8. Medtronic plc (U.S.)
  11.8.1. Company Overview
  11.8.2. Company Financials
  11.8.3. Product Portfolio
  11.8.4. Recent Developments
 11.9. Abbott Laboratories (U.S.)
  11.9.1. Company Overview
  11.9.2. Company Financials
  11.9.3. Product Portfolio
  11.9.4. Recent Developments
 11.10. Novo Nordisk A/S (Denmark)
  11.10.1. Company Overview
  11.10.2. Company Financials
  11.10.3. Product Portfolio
  11.10.4. Recent Developments
(Note: Financials are captured for public listed companies)

Key questions addressed by the research report-

  1. What are the current market trends and future market forecast from 2020 to 2026 for diabetes monitoring devices market?
  2. What are the market dynamics and probable opportunities for market players during the forecast period?
  3. Initiatives undertaken by market players to address the COVID-19 impact to sustain in the competitive market
  4. Which geographies have immense opportunities in different segments of the diabetes monitoring devices market?
  5. What are the recent strategies adopted by market players such as product launch, partnership, agreement, collaboration, merger & acquisition, and geographical expansion?


    Have any question? Check your free sample before purchase or connect with our expert.

    Additional information

    Licensing Types

    , , ,

    Enquire about Diabetes Monitoring Devices Market Analysis by Product (Continuous Monitoring, Self-Monitoring), by Distribution Channel (Hospital, Retail, Online), by End User (Hospitals, Homecare Setting, Diagnostic Centre), and by Region - Forecast to 2026